Live Breaking News & Updates on Healthcare Reits|Page 6

Stay updated with breaking news from Healthcare reits. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

J&J seeks permission for clinical trial of single-shot Covid vaccine in India


Global healthcare major Johnson & Johnson on Tuesday said it has sought an approval from the India s drug regulator to conduct a bridging clinical trial of its single-dose Covid-19 vaccine in the country.
The US Food and Drug Administration (USFDA) had in February approved Johnson & Johnson s Covid-19 vaccine that works with just one dose for emergency use.
Johnson & Johnson is partnering with health authorities and the world s best scientists to provide the safety and efficacy data necessary to support worldwide emergency use of the Janssen Covid-19 vaccine candidate, the company said ina statement.
This comes close on the heels of the central government last week deciding to fast-track emergency approvals for all foreign produced coronavirus jabs that have been given a similar nod by the World Health Organization or regulators in the United States, Europe, Britain or Japan. ....

United States , United Kingdom , Oxford Astrazeneca , Janssen Covid , Johnson Covid , National Institute Of Virology , World Health Organization , Drug Administration , Indian Council Of Medical Research , Serum Institute Of India , Oxford University , New Drugs , Clinical Trials Rules , Drugs Controller General , Bharat Biotech , Indian Council , Medical Research , Serum Institute , Covid 19 Vaccines , Clinical Trials , Covid 19 , Health Sciences , Covid 19 Vaccine , Bharat Biotech , Serum Institute Of India , Ohnson Amp Johnson ,